Effects of COVID‐19 on mastectomy and breast reconstruction rates: A national surgical sample
- 12 April 2022
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 126 (2) , 205-213
Abstract
Background: The COVID‐19 pandemic profoundly impacted breast cancer treatment in 2020. Guidelines initially halted elective procedures, subsequently encouraging less invasive surgeries and restricting breast reconstruction options. We examined the effects of COVID‐19 on oncologic breast surgery and reconstruction rates during the first year of the pandemic.Methods: Using the National Surgical Quality Improvement Program, we performed an observational examination of female surgical breast cancer patients from 2017 to 2020. We analyzed annual rates of lumpectomy, mastectomy (unilateral/contralateral prophylactic/bilateral prophylactic), and breast reconstruction (alloplastic/autologous) and compared 2019 and 2020 reconstruction cohorts to evaluate the effect of COVID‐19.Results: From 2017 to 2020, 175 949 patients underwent lumpectomy or mastectomy with or without reconstruction. From 2019 to 2020, patient volume declined by 10.7%, unilateral mastectomy rates increased (70.5% to 71.9%, p = 0.003), and contralateral prophylactic mastectomy rates decreased. While overall reconstruction rates were unchanged, tissue expander reconstruction increased (64.0% to 68.4%, p < 0.001) and direct‐to‐implant and autologous reconstruction decreased. Outpatient alloplastic reconstruction increased (65.7% to 73.8%, p < 0.0001), and length of hospital stay decreased for all reconstruction patients (p < 0.0001).Conclusions: In 2020, there was a nearly 11% decline in breast cancer surgeries, comparable mastectomy and reconstruction rates, increased use of outpatient alloplastic reconstruction, and significantly reduced in‐hospital time across all reconstruction types.Keywords
This publication has 27 references indexed in Scilit:
- Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. the COVID-19 pandemic breast cancer consortiumBreast Cancer Research and Treatment, 2020
- WHO Declares COVID-19 a Pandemic2020
- Autologous Breast Reconstruction versus Implant-Based Reconstruction: How Do Long-Term Costs and Health Care Use Compare?Plastic and Reconstructive Surgery, 2020
- Autologous versus implant-based breast reconstruction: A systematic review and meta-analysis of Breast-Q patient-reported outcomesJournal of Plastic, Reconstructive & Aesthetic Surgery, 2020
- Outcomes of immediate versus delayed breast reconstruction: Results of a multicenter prospective studyThe Breast, 2018
- Comparison of Wound Complications After Immediate, Delayed, and Secondary Breast Reconstruction ProceduresJAMA Surgery, 2017
- Direct-to-implant breast reconstruction: An analysis of 1612 cases from the ACS-NSQIP surgical outcomes databaseJournal of Plastic Surgery and Hand Surgery, 2014
- A Paradigm Shift in U.S. Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- A Paradigm Shift in U.S. Breast ReconstructionPlastic and Reconstructive Surgery, 2013
- Complications in Postmastectomy Breast Reconstruction: Two-Year Results of the Michigan Breast Reconstruction Outcome StudyPlastic and Reconstructive Surgery, 2002